Skip to main content
Top
Published in: Journal of Gastroenterology 3/2010

01-03-2010 | Original Article—Liver, Pancreas, and Biliary Tract

Natural course of the remnant hepatic functional reserve as estimated by technetium-99m-galactosyl human serum albumin scintigraphy after a hepatectomy

Authors: Yoshinori Shimizu, Takeshi Aoki, Tomokazu Kusano, Kazuhiro Matsuda, Yuta Enami, Daisuke Yasuda, Tomotake Koizumi, Takashi Niiya, Noriyuki Murai, Hirohisa Kato, Mitsuo Kusano, Masahiko Murakami

Published in: Journal of Gastroenterology | Issue 3/2010

Login to get access

Abstract

Background

Technetium-99m-galactosyl human serum albumin (GSA) scintigraphy provides an accurate estimation of the hepatic functional reserve but is not applied after a hepatectomy. The aim of this study was to elucidate the natural course of the remnant hepatic functional reserve (RHFR) after hepatectomy by GSA scintigraphy.

Methods

Eighty-six patients (partial hepatic resection, Hr0 = 46; sectionectomy, Hr1 = 21; bisectionectomy, Hr2 = 19) classified as Child–Pugh class A before the hepatectomy were enrolled, and GSA scintigraphy to detect HH15 (uptake ratio of the heart at 15 min to that at 3 min) and LHL15 (uptake ratio of the liver at 15 min to the liver plus the heart at 15 min) was performed periodically before and after the hepatectomy. HH15, LHL15, and the percentages of patients that recovered to the preoperative levels of these entities were estimated. In addition, hematobiochemical tests and the remnant liver volume were also periodically monitored.

Results

HH15 and LHL15 levels deteriorated until 2 months postoperatively (PO) after the procedure and subsequently recovered to the preoperative levels at 6 months PO in Hr0 patients. In Hr1 patients, but not in Hr2 patients, these levels also deteriorated until 3 months PO and had improved by 6 months after the surgery. Only 40% of the patients showed recovery to the preoperative levels by 6 months PO in the Hr0 group; furthermore, the percentage of patients who showed recovery to the preoperative levels by 6 months PO was under 40% in the Hr1 group and around 10% in the Hr2 group. However, the results of hematobiochemical tests and the remnant liver volume in all types of hepatectomies were rapidly normalized after the hepatectomy.

Conclusions

Remnant hepatic functional reserve estimated by GSA scintigraphy revealed that a larger resected liver volume induced both more serious and continued remnant hepatic dysfunction in comparison to results shown by hematobiochemical tests, while the functional regeneration was also appreciably slower and more gradual in comparison to the volume regeneration.
Literature
1.
go back to reference Jones SM, Roh MS. Results of surgical resection for hepatocellular carcinoma. Cancer Treat Res. 2001;109:59–75.PubMed Jones SM, Roh MS. Results of surgical resection for hepatocellular carcinoma. Cancer Treat Res. 2001;109:59–75.PubMed
2.
go back to reference Pedersen IK, Burcharth F, Roikjaer O, Baden H. Resection of liver metastases from colorectal cancer. Indications and results. Dis Colon Rectum. 1994;37:1078–82.CrossRefPubMed Pedersen IK, Burcharth F, Roikjaer O, Baden H. Resection of liver metastases from colorectal cancer. Indications and results. Dis Colon Rectum. 1994;37:1078–82.CrossRefPubMed
3.
go back to reference Jiao LR, Navarra G, Weber JC, Havlik R, Nicholls JP, Habib NA. Radiofrequency assisted liver resection—a novel technique. Hepatogastroenterology. 2005;52:1685–7.PubMed Jiao LR, Navarra G, Weber JC, Havlik R, Nicholls JP, Habib NA. Radiofrequency assisted liver resection—a novel technique. Hepatogastroenterology. 2005;52:1685–7.PubMed
4.
go back to reference Hotta T, Kobayashi Y, Taniguchi K, Johata K, Sahara M, Naka T, et al. Evaluation of postoperative nutritional state after hepatectomy for hepatocellular carcinoma. Hepatogastroenterology. 2003;50:1511–6.PubMed Hotta T, Kobayashi Y, Taniguchi K, Johata K, Sahara M, Naka T, et al. Evaluation of postoperative nutritional state after hepatectomy for hepatocellular carcinoma. Hepatogastroenterology. 2003;50:1511–6.PubMed
5.
go back to reference Shinomi S. Evaluation of hepatic functional reserve by scintigraphy with (99m) Tc-GSA. Hepatol Res. 2005;31:124–6.CrossRef Shinomi S. Evaluation of hepatic functional reserve by scintigraphy with (99m) Tc-GSA. Hepatol Res. 2005;31:124–6.CrossRef
6.
7.
go back to reference Kadono J, Kumemura H, Nishida S, Nakamura N, Gejima K, Makajo K, et al. 99mTc-DTPA-galactosyl-human-serum-albumin liver scintigraphy for evaluating hepatic functional reserve before hepatectomy in a patient with indocyanine green excretory defect: report of a case. Surg Today. 2006;36:481–4.CrossRefPubMed Kadono J, Kumemura H, Nishida S, Nakamura N, Gejima K, Makajo K, et al. 99mTc-DTPA-galactosyl-human-serum-albumin liver scintigraphy for evaluating hepatic functional reserve before hepatectomy in a patient with indocyanine green excretory defect: report of a case. Surg Today. 2006;36:481–4.CrossRefPubMed
8.
go back to reference Nanashima A, Yamaguchi H, Shibasaki S, Morino S, Ide N, Takeshita H, et al. Relationship between indocyanine green test and technetium-99m galactosyl serum albumin scintigraphy in patients scheduled for hepatectomy: clinical evaluation and patient outcome. Hepatol Res. 2004;28:184–90.CrossRefPubMed Nanashima A, Yamaguchi H, Shibasaki S, Morino S, Ide N, Takeshita H, et al. Relationship between indocyanine green test and technetium-99m galactosyl serum albumin scintigraphy in patients scheduled for hepatectomy: clinical evaluation and patient outcome. Hepatol Res. 2004;28:184–90.CrossRefPubMed
9.
go back to reference Kawamura E, Shinomi S, Ishizu H, Torii K, Kawabe J, Habu D, et al. Natural course of changes in hepatic functional reserve in patients with chronic liver diseases evaluated by scintigraphy with GSA. Hepatol Res. 2003;27:129–35.CrossRefPubMed Kawamura E, Shinomi S, Ishizu H, Torii K, Kawabe J, Habu D, et al. Natural course of changes in hepatic functional reserve in patients with chronic liver diseases evaluated by scintigraphy with GSA. Hepatol Res. 2003;27:129–35.CrossRefPubMed
10.
go back to reference Haga J, Shimazu M, Wakabayashi G, Tanabe M, Kawachi S, Fuchimoto Y, et al. Liver regeneration in donors and adult recipients after living donor liver transplantation. Liver Transplant. 2008;14:1718–24.CrossRef Haga J, Shimazu M, Wakabayashi G, Tanabe M, Kawachi S, Fuchimoto Y, et al. Liver regeneration in donors and adult recipients after living donor liver transplantation. Liver Transplant. 2008;14:1718–24.CrossRef
11.
go back to reference Kwon AH, Matsui Y, Kaibori M, Kamiyama Y. Functional hepatic regeneration following hepatectomy using galactosyl-human serum albumin liver scintigraphy. Transplant Proc. 2004;36:2257–60.CrossRefPubMed Kwon AH, Matsui Y, Kaibori M, Kamiyama Y. Functional hepatic regeneration following hepatectomy using galactosyl-human serum albumin liver scintigraphy. Transplant Proc. 2004;36:2257–60.CrossRefPubMed
Metadata
Title
Natural course of the remnant hepatic functional reserve as estimated by technetium-99m-galactosyl human serum albumin scintigraphy after a hepatectomy
Authors
Yoshinori Shimizu
Takeshi Aoki
Tomokazu Kusano
Kazuhiro Matsuda
Yuta Enami
Daisuke Yasuda
Tomotake Koizumi
Takashi Niiya
Noriyuki Murai
Hirohisa Kato
Mitsuo Kusano
Masahiko Murakami
Publication date
01-03-2010
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 3/2010
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-009-0144-5

Other articles of this Issue 3/2010

Journal of Gastroenterology 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine